The presence of a phospholipase A2 (PLA2) activity in rabbit neutrophil membrane preparation that is able to release [1-1'C]oleic acid from labelled Escherichia coli has been demonstrated. The activity is critically dependent on the free calcium concentration and marginally stimulated by GTPyS. More than 80 % of maximal activity is reached at 10 p,M-Ca2+. The chemotactic factor, fMet-Leu-Phe, does not stimulate the PLA2 activity in this membrane preparation. Pretreatment of the membrane preparation, under various experimental conditions, or intact cells, before isolation of the membrane with phorbol 12-myristate 13-acetate (PMA), does not affect PLA2 activity. Addition of the catalytic unit of cyclic AMP-dependent kinase to membrane preparation has no effect on PLA2 activity. Pretreatment of the intact neutrophil with dibutyryl-cAMP before isolation of the membrane produces a small but consistent increase in PLA2 activity. The activity of PLA2 in membrane isolated from cells treated with the protein kinase inhibitor 1-(5-isoquinolinesulphonyl)-2-methyl piperazine dihydrochloride (H-7) is significantly decreased. Furthermore, although the addition of PMA to intact rabbit neutrophils has no effect on the release of [3H]arachidonic acid from prelabelled cells, it potentiates significantly the release produced by the calcium ionophore A23 187. This potentiation is not due to an inhibition of the acyltransferase activity. H-7 inhibits the basal release of arachidonic acid but does not inhibit the potentiation by PMA. These results suggest several points. (1) fMet-Leu-Phe does not stimulate PLA2 directly, and its ability to release arachidonic acid in intact neutrophils is mediated through its action on phospholipase C. (2) The potentiating effect of PMA on A23187-induced arachidonic acid release is most likely due to PMA affecting either the environment of PLA2 and/or altering the organization of membrane phospholipids in such a way as to increase their susceptibility to hydrolysis. (3) The intracellular level of cyclic AMP probably does not directly affect the activity of PLA2.
INTRODUCTION
In response to stimuli, many different cell types, including neutrophils, release arachidonic acid, which is then metabolized to generate one or more biologically active eicosanoids such as leukotrienes, prostaglandins and thromboxane (Lands & Samuelsson, 1968; Hirata et al., 1979; Billah et al., 1980; Corey et al., 1980; Rubin et al., 1981; Feinstein & Sha'afi, 1983; Flower, 1985; Alonso et al., 1986; Burch et al., 1986; Pollock et al., 1986; Smith & Waite, 1986; Godfrey et al., 1987) . Since the level of free arachidonic acid in the cytoplasm is low, the rate-limiting step in eicosanoid biosynthesis is the liberation of arachidonic acid (Irvine, 1982) . This, and the importance of the released eicosanoids in inflammatory reactions, has led to phospholipase A2 (PLA2) being thought of as a key enzyme in eicosanoid production and neutrophil physiology. Although it is generally agreed that activation of PLA2 is closely involved in the release of arachidonic acid from membrane phospholipids following stimulation, the various parameters that activate and regulate PLA2 activity are not well understood.
Recently Becker and his associates (Bormann et al., 1984) have reported that the addition of the chemotactic factor fMet-Leu-Phe to membrane preparation isolated from rabbit neutrophils stimulates PLA2 activity (as measured by the release of oleic acid from [1-'4C]oleic acid-labelled E. coli). This indicates that chemotactic factors release arachidonic acid in intact cells, by activating PLA2 directly, and not through increasing the concentration of intracellular free calcium by the generation of inositol 1,4,5-trisphosphate. If it is true, this finding is quite important.
In neutrophils, Volpi et al. (1985) have shown that the active phorbol esters potentiate arachidonic acid release produced by the calcium ionophore A23187. Similar results were found in platelets (Halenda et al., 1985; Mobley & Tai, 1985) . Although other explanations are possible (Pollock et al., 1986) , this potentiation has been interpreted in terms of activating PLA2 by the protein kinase C system.
MATERIALS AND METHODS Preparation of cells
Rabbit peritoneal neutrophils were obtained 12-14 h after intraperitoneal injection of 0.1 % glycogen saline. Cells were washed and resuspended in Hanks balanced Vol. 250
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* To whom correspondence should be addressed. salt solution buffered with 10 mM-Hepes as previously described (Matsumoto et al., 1987) . In the experiment where the agents were added to the intact cells, neutrophil suspensions (108 cells/ml) were incubated with either fMet-Leu-Phe (10-i M, 30 s), PMA (50 ng/ml, 3 min), dibutyryl cyclic AMP (2 mm, 10 min), H-7 (25 /SM, 5 min) or dimethyl sulphoxide (0.05 %), at 37 'C.
Membrane preparation
The suspensions were centrifuged, washed once, and then resuspended in ice-cold sucrose-buffered solution [0.25 M-sucrose/10 mM-Hepes (pH 7.5)/I mM-EGTA] containing 1 mM-GDP, 1 mM-di-isopropyl fluorophosphate and 50 ,ug of leupeptin/ml. Suspensions were kept at 4 'C. The cells were homogenized by nitrogen cavitation (13.8 kPa) for 20 min. The homogenate was centrifuged at 8200 g for 30 min and the supernatants were then centrifuged at 100000 g for 60 min. The pellets were resuspended in sucrose buffer and used for measuring the PLA2 activity. Protein concentration was measured using Bio-Rad protein assay (Bradford, 1976) .
In the experiments for membrane treatment, the membrane was incubated with or without either PMA (50 ng/ml) or the catalytic unit of cyclic AMP-dependent kinase (45 units/ml), in the presence of ATP (100 ,M)/ Tris/HCI (pH 7.5, 50 mM)/MgCl2 (10 mM)/ouabain (250 /tM)/Ca2+ (0.5 mM only when PMA was used) at 37 'C for 30 min. The membranes were washed once and resuspended in sucrose-buffered solution. Measurement of PLA2 actiVty [1-14C]Oleic acid-labelled E. coti substrate was prepared as previously reported (Victor et al., 1981 Schwarzenbach et al. (1957) and Owen (1976) . The reactions were stopped by extraction of the lipids with 0.75 ml of methanol/chloroform (2:1, v/v), followed by 0.25 ml each of chloroform and water as described by Bligh & Dyer (1959) and Volpi et al. (1985) . The recovered lipids in the chloroform layer were separated by t.l.c. in hexane/ether/acetic acid (40:60: 1, by vol.) on precoated silica-gel plates (Volpi et al., 1985) .
The hydrolysed [1-14C]oleic acid was scraped and its radioactivity was determined in a Searly Delta 300 scintillation counting system. Cell labelling Labelling was carried out as previously described (Volpi et al., 1984 Isolation and separation of lipids Lipids were isolated and separated as previously described (Volpi et al., 1984) . After the reaction was terminated, the samples were mixed with a vortex and kept overnight at 4 'C. The samples were again mixed with a vortex for I min and centrifuged at 800 g for 5 min to separate the two phases. The upper organic phase was removed and transferred to another set of test tubes. Portions of 2 ml of hexane were added to the remaining water phase, and the tubes were again mixed with a vortex for 15 s and centrifuged as before. The top hexane layer was removed and pooled with the previous one. The organic phase was dried under a stream of nitrogen and the lipids were dissolved in 100 ,1 of hexane/ isopropanol (3:2, v/v).
To separate neutral lipids, portions of 20 ,u were used to spot silica-gel 60 precoated t.l.c. plates. Arachidonic acid (1.75 ,ug) was added at the origin with the samples to help in the visualization of the lipids with 12 vapour. The plates were developed in chloroform/acetone (96:4, v/v). After exposure to the 12 vapour, the arachidonic acid was outlined with a pencil and the plate was sprayed lightly with water. The corresponding silica was carefully scraped from the plate with a razor blade, collected, and assayed for radioactivity.
Lysolecithin acyltransferase
The activity of lysolecithin acyltransferase was measured in a total volume of 200 ,ul containing 20 ,1 of neutrophil homogenate (5 ,ug of protein), 50 /SM-I-[1-'4C]palmitoyl-sn-glycero-3-phosphocholine (2 mCi/ mmol), 30 ,M-arachidonoyl-CoA, 140 mM-KCl and 20 mM-Hepes (pH 7.4). The reaction was carried out at 37 'C for 10 min and then terminated by extraction of lipids with 0.75 ml of methanol/chloroform (2:1, v/v) and 0.25 ml each of chloroform and water as described above. The synthesized phosphatidylcholine in the chloroform layer was separated by t.l.c. on precoated silica plates in chloroform/methanol/acetic acid/0.9 % NaCl (50:25:8:4, by vol.) . The spot of phosphatidylcholine visualized by iodine vapour was cut and counted in the scintillation counter. Chemicals conditions, it has been shown by Becker and his associates (Lanni & Becker, 1983; Bormann, 1985) , using Calcium requirement for PLA2 activation The effect of free calcium concentration on PLA2 activity was investigated using the Ca2+-EGTA buffer system. In these experiments, the free calcium concentration was calculated using the stability constant between Ca2+ and EGTA as described in the Materials and methods section. The results summarized in Fig. 1 clearly show that PLA2 activity has a sharp dependence on Ca2+. The activity reached a plateau at about 250 /SMCa2+. Higher concentrations of Ca21 (1 and 5 mM) were also used and the results were the same.
The ability of guanine nucleotide to modulate PLA2 activity was also examined. The reactions were carried out in the presence or absence of several guanine nucleotides and their analogues. Neither GTP nor GDP had any effect on PLA2 activity. In addition, GTPyS and guanylylimidodiphosphate, non-hydrolysable analogues of GTP, increased the maximal activity of PLA2 by no more than 10%.
Effect of fMet-Leu-Phe on PLA2 activity
The effect of the chemotactic factor fMet-Leu-Phe on PLA2 activity has been investigated. In these studies, two sets of experiments were carried out. In the first set, fMet-Leu-Phe was added to the membrane preparation before the addition of membrane to the reaction mixture. In the second set, intact neutrophils were treated with fMet-Leu-Phe (10-' M) for 30 s, washed once, and then the cells used to prepare membrane; the results are summarized in Fig. 2 Effects of PMA and the catalytic unit of cyclic AMPdependent kinase on PLA2 activity of membrane preparation In order to examine the roles of protein kinase C and the cyclic AMP-dependent kinase (A-kinase) on PLA2 activity, we have carried out two sets of experiments. In the first set, the membrane preparation was incubated in the presence of 100 ,tM-ATP with either PMA (50 ng/ml) or the catalytic unit of cyclic AMP-dependent kinase (45 units/ml) as described in the Materials and methods section. Then the membrane was washed, resuspended in sucrose-buffered solution, and used for measurement; the results are summarized in Table 2 . It is quite clear from the Table that neither PMA nor A-kinase has any significant effect on PLA2 activity (as measured by the amount of [1-"C]oleic acid released). In separate experiments, the membrane preparation was treated with PMA as described in the Materials and methods section, except that the incubation medium contained, in addi- (6) 20605+ 3487 (9) 755 tion, neutrophil cytosol (either diluted or concentrated). Again PMA under these conditions has no effect on PLA2 activity (results not shown).
In the second set of experiments, intact neutrophils were treated either with PMA (50 ng/ml) for 3 min, 2 mM-dibutyryl cyclic AMP for 10 min or H-7 (25 /,M) for 5 min, washed once and then used to prepare membrane; the results are summarized in Table 3 . As in the case for membrane, PMA added to the intact cell fails to produce any significant effect on PLA2 activity. The addition of dibutyryl cyclic AMP to intact cells produces a small increase in PLA2 activity. On the other hand, pretreatment of the intact neutrophils with H-7 produces significant (p < 0.01) inhibition. Basal and A23187-induced 13HI-arachidonic acid release in control, PMA, H-7, and PMA plus H-7-treated neutrophils The effects of PMA, H-7 and PMA plus H-7 on the basal and calcium ionophore (A23187)-induced [3H]- Table 3 . 11-14CIOleic acid release by membrane preparations isolated from control, PMA-, dibutyryl cyclic AMP-and H-7-treated rabbit neutrophils Prior to the isolation of the membrane preparation, the cells were treated with PMA (50 ,g/ml) for 3 min or dibutyryl cyclic AMP (2 mM) for 10 min or H-7 (25 /M) for 5 min, washed once and then used for membrane preparation. arachidonic acid release in rabbit neutrophils were investigated (Table 4 ). These results show that while PMA has no effect on the basal release, it potentiates significantly (P < 0.001) the release produced by the calcium ionophore. In addition, H-7 inhibits the basal release but not the potentiation by PMA. This potentiation by PMA of arachidonic acid release produced by the ionophore could be mediated through an inhibition of the re-incorporation of the released arachidonic acid into phospholipids. To examine this, we have measured the activity of lysolecithin acyltransferase in neutrophil homogenates of control and PMA-treated cells (Table 5) . In these studies, the time course (0-20 min) of the activity of lysolecithin acyltransferase was determined (results not shown). Phosphatidylcholine production increased linearly with time in the first 10 min. The effect of varying the membrane protein concentration in the reaction mixture on the amount of phosphatidylcholine produced was also examined. The kinetics of production indicated that the reaction is linear with up to 10,ug of protein. It is clear from the results in Table 5 that pretreatment with PMA does not inhibit significantly lysolecithin acyltransferase activity.
DISCUSSION
The results reported here demonstrate the presence of a PLA2 activity in membrane preparations isolated from rabbit neutrophils. The activity of this enzyme requires the presence of calcium, and at best, can be marginally (< 10 %) potentiated by non-hydrolysable GTP analogues. The activity of this enzyme is extremely sensitive to variations in the concentration of free calcium in the range 1-10,OM-Ca2 .
The chemotactic factor, fMet-Leu-Phe, added either to the membrane preparation or to intact cells before the isolation of the membrane, failed to stimulate PLA2 activity. The inability of fMet-Leu-Phe, when added to the intact neutrophils before the preparation of the membrane, to stimulate PLA2 activity was not unexpected because of the transient nature of fMet-LeuPhe-induced effects. On the other hand, the failure of fMet-Leu-Phe to stimulate PLA2 activity when added directly to the membrane was quite unexpected since it was in conflict with published results (Bormann et al., 1984) . Using similar membrane preparation and experimental techniques, these authors have found that fMet-Leu-Phe (1 nM) stimulated PLA2 activity 3-fold. Although the basis for this discrepancy is not known, it cannot be due to differences in the experimental methods.
We have reported previously that the addition of PMA to intact rabbit neutrophils potentiates [3H]arachidonic acid release by the calcium ionophore A23187 (Volpi et al., 1985) . Similar results have been found in platelets (Halenda et al., 1985; Mobley & Tai, 1985) . Based on these findings, it has been suggested that activation of protein kinase C by PMA positively modulates the activity of PLA2. We have reconfirmed this potentiation. In addition, we have shown that this potentiation is not inhibited by H-7. This enhancing effect is not due to PMA action on the metabolism of arachidonic acid by either the lipoxygenase or the cyclo-oxygenase pathway (Halenda et al., 1985; McColl et al., 1986) . Furthermore, since the activity of lysolecithin acyltransferase in homogenates isolated from control or PMA-treated neutrophils is the same, the observed potentiation by PMA cannot be due to an inhibition of the reincorporation of released arachidonic acid into phospholipids.
Since the addition of PMA, under different experimental conditions, does not stimulate PLA2 activity, it is reasonable to conclude that its potentiating action is not mediated through a direct effect on the enzyme. In intact cells, PMA, either directly or indirectly, could potentiate the A23187-induced arachidonic acid release by affecting the environment of PLA2. Another possibility is that PMA may alter the organization of membrane phospholipids in such a way as to increase their susceptibility to hydrolysis. Although a role for protein kinase C cannot be ruled out completely, the inability of H-7 to inhibit the PMA-induced potentiation, suggests that PMA produces its action, in part, by direct membrane perturbation. A similar hypothesis was advanced for regulating arachidonate liberation in platelets in response to collagen at low intracellular free calcium concentrations (Pollock et al., 1986) . Although the potentiation by PMA appears to be mediated by events other than a direct effect on the enzyme, one must not conclude that PLA2 activity in intact cells is independent of protein kinase C activity. It is conceivable that, in these cells, the basal activity of protein kinase C is sufficient to produce the maximal influence of protein kinase C on phospholipase A2 activity. In fact, we would like to hypothesize that the basal activity of PLA2 is modulated to some degree by H-7-sensitive kinase (probably protein kinase C). There are two experimental observations which are consistent with this view. (1) PLA2 activity in membrane isolated from H-7-treated neutrophils is significantly (P < 0.01) decreased. (2) The amount of [3H]arachidonic acid released under basal conditions is significantly reduced in H-7-treated neutrophils.
Since neither the active unit of cyclic AMP-dependent kinase nor the addition of dibutyryl cyclic AMP greatly affects the activity of PLA2, it is reasonable to conclude that intracellular variations of cyclic AMP levels, in intact cells, may not modulate, directly, PLA2 activity. This does not rule out an indirect effect of cellular cyclic AMP on stimulated liberation of arachidonic acid. One possibility is that cyclic AMP may affect the intracellular level of free calcium, and/or it may affect one or more Vol. 250 steps in the sequence of events leading to the generation of arachidonic acid.
